Type 1 CFI RV genotypes were identified in Finnish dry AMD at a 5–10-fold lower level than found across European advanced AMD (0.212% versus 1.008% to 2.59%) [15], suggesting that genetic restriction in Finland has had an impact on the prevalence of CFI variants. Here, CFI is linked to dry age related macular degeneration.